Pharmaceutical Formulation Development of Peptides and Proteins, 2E

Status

Published

on 29 Nov 2012

Year of Creation

2012

Taylor and Francis

Registration Number

TX0007680876

on 29 Nov 2012

The U.S. Copyright record (Registration Number: TX0007680876) dated 29 Nov 2012, pertains to an electronic file (eService) titled "Pharmaceutical Formulation Development of Peptides and Proteins, 2E" created in 2012. The copyright holder is Taylor and Francis, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Taylor and Francis.

Taylor and Francis

Application Details

Registration Number

TX0007680876

Registration Date

11/29/2012

Year of Creation

2012

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Book, 376 p

First Publication Nation

United States

ISBN

9781439853887

Personal Authors

Corporate Authors

Notes

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Pharmaceutical Formulation Development of Peptides and Proteins, 2E

Author Statement: Lars Hovgaard Domicile: Denmark Authorship: text, compilation, editing Sven Frokjaer Domicile: Denmark Authorship: text, compilation, editing Marco van de Weert Domicile: Denmark Authorship: text, compilation, editing

Notes

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Pharmaceutical Formulation Development of Peptides and Proteins, 2E

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.